Vortrag am FONDS professionell KONGRESSFranklin Genomic Advancements Fund - N (acc) EUR
| MVD-Fonds Rating | EDA |
|---|---|
  | - |
ISIN: LU2387457729 | WKN: A3C4V6
KAG: Franklin Templeton
NAV: 7,47 EUR am 17.08.2026
Portfolio
Watchlist
KursalarmChart
Kennzahlen Franklin Genomic Advancements Fund - N (acc) EUR
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +2,75% | +19,14% | +38,08% | +22,46% | - | - | -25,30% |
| Volatilität | +23,48% | +23,34% | +21,27% | +20,89% | - | - | +22,26% |
| Sharpe Ratio | +1,50 | +1,71 | +1,68 | +0,21 | - | - | -0,38 |
| Bester Monat | - | +14,82% | +15,60% | +15,60% | +15,60% | - | +15,60% |
| Schl. Monat | - | -5,34% | -5,59% | -11,80% | -18,20% | - | -18,20% |
| Max. Verlust | -3,16% | -9,75% | -17,88% | -30,65% | - | - | -55,71% |
Monatsperformance Franklin Genomic Advancements Fund - N (acc) EUR
| 2026 | 2025 | 2024 | 2023 | 2022 | |
| Januar | -0,46% | +5,79% | -0,33% | +3,62% | -18,20% |
| Februar | -5,34% | -4,69% | +7,72% | -3,95% | -3,75% |
| März | -2,42% | -11,80% | +1,83% | -0,47% | -0,78% |
| April | -0,66% | -3,90% | -7,34% | -3,50% | -7,59% |
| Mai | +6,48% | -5,42% | +1,45% | +1,81% | +0,42% |
| Juni | +14,82% | +3,27% | +3,18% | 0,00% | -1,55% |
| Juli | -3,80% | +3,17% | +4,78% | +2,59% | +12,75% |
| August | +5,51% | +4,80% | -3,24% | -0,32% | -8,01% |
| September | - | +3,30% | -3,65% | -5,70% | -5,39% |
| Oktober | - | +15,60% | -4,90% | -10,23% | +3,36% |
| November | - | +7,06% | +5,32% | +5,98% | -1,84% |
| Dezember | - | -5,59% | -4,57% | +7,76% | -8,63% |
| Gesamt | +13,35% | +8,93% | -0,99% | -3,78% | -35,08% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (Franklin Genomic Advancements Fund) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds